Tuberculosis and Hepatitis

Most healthy people’s immune systems kill or contain TB infection without developing symptoms. Latent TB infection is an asymptomatic and non-transmissible form of TB. Hepatitis is an inflammation of the liver. There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. Twin studies of tuberculosis (TB) and chronic hepatitis B virus (HBV) infection identified a strong host genetic component to individual variability in disease susceptibility. Short-course chemotherapy containing rifampicin and isoniazid in combination has proved to be highly effective in the treatment of tuberculosis, but one of its adverse effects is hepatotoxicity. An estimated 49 million lives were saved through TB diagnosis and treatment between 2000 and 2015. 

  • Tuberculosis and STD
  • TB and HIV coinfection
  • Prevalence
  • Tuberculosis - Health impact
  • Hepatotoxicity
  • Pulmonary/Extrapulmonary TB 
  • Tuberculosis in children
  •  Risk Factors
  • Types of hepatits
  • Acute hepatitis
  • Hepatitis C Coalition
  • Chronic hepatitis
  • Hepatic cirrhosis
  • Auto immune hepatitis
  • Liver disorders
  • Causes, Symptoms and Treatments

Related Conference of Tuberculosis and Hepatitis

August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA
December 07-08, 2017

EuroSciCon Conference on STD-AIDS

Rome, Italy
March 1-2, 2018

5th International congress on Infectious Diseases

Berlin, Germany
June 18-19, 2018

EuroSciCon Conference on Bacteriology

Paris, France

Tuberculosis and Hepatitis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in